The Pfizer-BNT162b2 mRNA-based vaccine against SARS-CoV-2 may be responsible for awakening the latency of herpes varicella-zoster virus.

Maldonado, M D; Romero-Aibar, J.

Afiliação

Maldonado MD; Department of Medical Biochemistry, Molecular Biology, and Immunology, University of Seville Medical School, Spain.
Romero-Aibar J; Superior Laboratory Technician, Department of External Analysis Service, IRNAS (CSIC) Seville, Spain.

Brain Behav Immun Health ; 18: 100381, 2021 Dec.

Article em En | MEDLINE | ID: mdl-34746880

Palavras-chave

APC, Professional antigen presenting cells. COVID-19; Angiotensin-Converting Enzyme Inhibitor. RT-PCR, Reverse transcriptase polymerase chain reaction. S protein: Transmembrane spike glycoprotein. SARS-CoV-2; Coronavirus Disease 2019. HLA, Human leukocyte antigens. IACE; Herpes zoster infection; Immune system; Severe Acute Respiratory Syndrome Coronavirus. VZV, Herpes virus varicella zoster; The anti-SARS-CoV-2 vaccines; mRNA-based vaccines

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article